Superior venocaval obstruction secondary to central venous catheter-related thromboses in two patients with metastatic colorectal carcinoma receiving weekly 5-flurouracil. Should adjusted-dose warfarin be used as thromboprophylaxis?

Blood Coagulation and Fibrinolysis

Volumn 13, Issue 8, 2002, Pages 749-753

  Mainwaring, C J ^a,c   Naylor, E ^a   Jerwood, S ^a   Hall, V ^b   Page, A ^a   James, C M ^a  

^a ROYAL HAMPSHIRE COUNTY HOSPITAL   (United Kingdom)

^b ROYAL SOUTH HANTS HOSPITAL   (United Kingdom)

^c NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

Author keywords

Metastatic carcinoma; Superior venocaval thrombosis

Indexed keywords

FIBRINOLYTIC AGENT; FLUOROURACIL; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTINUOUS INFUSION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; INCIDENCE; LIVER METASTASIS; MALE; METASTASIS; PHLEBOGRAPHY; PRIORITY JOURNAL; PROPHYLAXIS; STANDARD; SUPERIOR CAVA VEIN OBSTRUCTION; VEIN THROMBOSIS;

AGED; ANTICOAGULANTS; ANTINEOPLASTIC AGENTS; CATHETERIZATION, CENTRAL VENOUS; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; THROMBOEMBOLISM; VENOUS THROMBOSIS; WARFARIN;

EID: 0036914990     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200212000-00012     Document Type: Article

References (8)

1. Rickles FR, Levine MN. Venous thromboembolism in malignancy and malignancy in venous thromboembolism. Haemostasis 1998; 28: 43-49.
2. Otten Hans-Martin MB, Prins MH, Smorenburg SM, Hutten BA. Risk assessment and prophylaxis of venous thromboembolism in non-surgical patients: cancer as a risk factor. Haemostasis 2000; 30: 72-76.
3. Monreal M, Raventos A, Lerrna R, Ruiz J, Lafoz E, Alastrue A, Llamazares JF. Pulmonary embolus in patients with upper limb DVT associated to central lines. A prospective study. Thromb Haemost 1994; 72: 548-550.
4. De Cicco M, Matovic M, Balestreri L, De Angelis V, Fracasso A, Morassut S, et al. Antithrombin deficiency as a risk factor for catheter related central vein thrombosis in cancer patients. Thromb Res 1995; 78: 127-137.
5. Bern MM, Lokich JJ, Wallach SR. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomised prospective trial. Ann Intern Med 1990; 112: 423-428.
6. Boraks P, Searle J, Price J, Bass G, Ethell M, Keeling D, et al. Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies. Br J Haematol 1998; 101: 483-486.
7. Monreal M, Alastrue A, Rull M, Mira X, Muxart J, Rosell R, Abad A. Upper extremity deel venous thrombosis in cancer patients with venous access devices-prophylaxis with a low molecular weight heparin (fragmin). Thromb Haemost 1995; 74: 606-611.
8. Biffi R, De Braud F, Orsi F, Pozzi S, Arnaldi P, Goldhirsch A, et al. A randomised prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adut oncology patients. Cancer 2001; 92:1204-1212.